GREAT POINT PARTNERS LLC
Top Portfolio Positions
42 positions ·
$453,101,803 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
374,000 | $31,479,580 | 6.95% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
1,750,000 | $31,220,000 | 6.89% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
4,215,930 | $25,084,783 | 5.54% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
1,750,000 | $24,325,000 | 5.37% | |
| IBRX |
ImmunityBio, Inc.
Healthcare
|
3,000,800 | $23,016,136 | 5.08% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
316,453 | $22,768,793 | 5.03% | |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
274,363 | $21,735,036 | 4.80% | |
| ALMS |
Alumis Inc.
Healthcare
|
856,061 | $18,859,023 | 4.16% | |
| PMN |
ProMIS Neurosciences Inc.
Healthcare
|
1,325,484 | $16,833,646 | 3.72% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
220,000 | $16,053,400 | 3.54% |
Portfolio Trend
25 quarters · across all stocks
Holdings in NGNE
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,080,000 | 500,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,210,000 | 350,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,743,286 | 446,814 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,263,592 | 485,859 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,514,988 | 470,964 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,121,516 | 442,761 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $42,140,050 | 1,004,291 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $36,546,149 | 1,004,291 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $51,118,411 | 1,004,291 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $19,268,158 | 994,229 | Shares | Defined | 2024-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||